Table III.
n = 745 (100%) |
Asia 158 (21.2) |
Europe 422 (56.6) |
N America 82 (11.0) |
S America 57 (7.8) |
Africa 16 (2.1) |
Oceania 10 (1.3) |
|
---|---|---|---|---|---|---|---|
Hospital involvement in COVID-19 care | |||||||
Fully dedicated | 125 (16.8) | 38 (24.1) | 68 (16.1) | 13 (15.9) | 4 (7.0) | 2 (12.5) | 0.0 (0) |
Partially dedicated | 569 (76.4) | 102 (64.5) | 326 (77.3) | 68 (82.9) | 53 (93.0) | 11 (68.7) | 9 (90.0) |
Not involved | 51 (6.8) | 18 (11.4) | 28 (6.6) | 1 (1.2) | 0.0 (0) | 3 (18.8) | 1 (10.0) |
Readily available | |||||||
External facilities for CRC surgery | 479 (64.3) | 103 (65.2) | 291 (69.0) | 26 (31.7) | 42 (73.7) | 10 (62.5) | 7 (70.0) |
Cancer care coordinator | 420 (56.4) | 80 (50.6) | 238 (56.4) | 57 (69.5) | 32 (56.1) | 7 (43.7) | 6 (60.0) |
Personal protective equipment | 638 (85.6) | 146 (92.4) | 357 (84.6) | 70 (85.4) | 44 (77.2) | 12 (75.0) | 9 (90.0) |
Status of elective CRC surgery | |||||||
Temporarily put on hold | 349 (46.8) | 73 (46.2) | 182 (43.1) | 60 (73.2) | 21 (36.8) | 8 (50.0) | 5 (50.0) |
≤4 weeks | 53 (15.2) | 8 (11.0) | 29 (15.9) | 7 (11.7) | 5 (23.8) | 4 (50.0) | 0.0 (0) |
5–8 weeks | 170 (48.7) | 37 (50.7) | 89 (48.9) | 33 (55.0) | 5 (23.8) | 3 (37.5) | 3 (60.0) |
>8 weeks | 126 (36.1) | 28 (38.3) | 64 (35.2) | 20 (33.3) | 11 (52.4) | 1 (12.5) | 2 (40.0) |
Temporarily reduced | 376 (50.5) | 83 (52.5) | 222 (52.6) | 22 (26.8) | 36 (63.2) | 8 (50.0) | 5 (50.0) |
≤50% | 190 (50.5) | 45 (54.2) | 114 (51.4) | 9 (50.9) | 17 (47.2) | 2 (25.0) | 3 (60.0) |
>50% | 186 (49.5) | 38 (45.8) | 108 (48.6) | 13 (59.1) | 19 (52.8) | 6 (75.0) | 2 (40.0) |
Unaffected | 20 (2.7) | 2 (1.3) | 18 (4.3) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) |
Elective CRC patients | |||||||
Needing urgent surgery | 196 (26.3) | 37 (23.4) | 122 (28.9) | 17 (20.7) | 15 (26.3) | 3 (18.8) | 2 (20.0) |
Initial CRC care plan | |||||||
Changed | 365 (49.0) | 86 (54.4) | 206 (48.8) | 31 (37.8) | 30 (52.6) | 9 (56.3) | 3 (30.0) |
CRC patients | |||||||
Refusing surgery | 300 (40.3) | 70 (44.3) | 154 (36.5) | 46 (56.1) | 25 (49.3) | 3 (18.8) | 2 (20.0) |
Being COVID-19+ on surgery | 145 (19.5) | 19 (12.0) | 109 (25.8) | 9 (11.0) | 7 (12.3) | 0.0 (0) | 1 (10.0) |
Becoming COVID-19+ postoperative | 198 (26.6) | 28 (17.7) | 146 (34.6) | 8 (9.8) | 13 (22.8) | 2 (12.5) | 1 (10.0) |
Staff members | |||||||
Quarantined | 388 (52.1) | 74 (46.8) | 245 (58.1) | 40 (48.8) | 23 (40.4) | 4 (25.0) | 2 (20.0) |
<10% | 179 (46.1) | 40 (54.1) | 104 (42.5) | 27 (67.5) | 7 (30.4) | 0.0 (0) | 1 (50.0) |
10–20% | 153 (39.5) | 28 (37.8) | 100 (40.8) | 11 (27.5) | 10 (43.5) | 3 (75.0) | 1 (50.0) |
>20% | 56 (14.4) | 6 (8.1) | 41 (16.7) | 2 (5.0) | 6 (26.1) | 1 (25.0) | 0.0 (0) |
Relocated to COVID units | 338 (45.4) | 66 (41.8) | 215 (50.9) | 39 (47.6) | 13 (22.8) | 3 (18.8) | 2 (20.0) |
<20% | 190 (56.2) | 49 (74.2) | 109 (50.7) | 23 (59.0) | 7 (53.8) | 1 (33.3) | 1 (50.0) |
20–40% | 54 (16.0) | 6 (9.1) | 33 (15.3) | 8 (20.5) | 4 (30.8) | 2 (66.7) | 1 (50.0) |
>40% | 94 (27.8) | 11 (16.7) | 73 (34.0) | 8 (20.5) | 2 (15.4) | 0.0 (0) | 0.0 (0) |
MDT meetings | |||||||
Suspended | 364 (48.9) | 102 (64.6) | 192 (45.5) | 31 (37.8) | 31 (54.4) | 7 (43.8) | 1 (10.0) |